Skip to main content
Top
Published in: Virology Journal 1/2006

Open Access 01-12-2006 | Research

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis

Authors: Sharon L Lederer, Kathie-Anne Walters, Sean Proll, Bryan Paeper, Shahar Robinzon, Loreto Boix, Nelson Fausto, Jordi Bruix, Michael G Katze

Published in: Virology Journal | Issue 1/2006

Login to get access

Abstract

Background

Little is known at the molecular level concerning the differences and/or similarities between alcohol and hepatitis C virus induced liver disease. Global transcriptional profiling using oligonucleotide microarrays was therefore performed on liver biopsies from patients with cirrhosis caused by either chronic alcohol consumption or chronic hepatitis C virus (HCV).

Results

Global gene expression patterns varied significantly depending upon etiology of liver disease, with a greater number of differentially regulated genes seen in HCV-infected patients. Many of the gene expression changes specifically observed in HCV-infected cirrhotic livers were expectedly associated with activation of the innate antiviral immune response. We also compared severity (CTP class) of cirrhosis for each etiology and identified gene expression patterns that differentiated ethanol-induced cirrhosis by class. CTP class A ethanol-cirrhotic livers showed unique expression patterns for genes implicated in the inflammatory response, including those related to macrophage activation and migration, as well as lipid metabolism and oxidative stress genes.

Conclusion

Stages of liver cirrhosis could be differentiated based on gene expression patterns in ethanol-induced, but not HCV-induced, disease. In addition to genes specifically regulating the innate antiviral immune response, mechanisms responsible for differentiating chronic liver damage due to HCV or ethanol may be closely related to regulation of lipid metabolism and to effects of macrophage activation on deposition of extracellular matrix components.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koike K: Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. Hepatol Res 2005,33(2):145-150. 10.1016/j.hepres.2005.09.023CrossRefPubMed Koike K: Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. Hepatol Res 2005,33(2):145-150. 10.1016/j.hepres.2005.09.023CrossRefPubMed
2.
go back to reference Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000, 20: 17-35. 10.1055/s-2000-9505CrossRefPubMed Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000, 20: 17-35. 10.1055/s-2000-9505CrossRefPubMed
3.
go back to reference Hines IN, Wheeler MD: Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2004, 287: G310-G314. 10.1152/ajpgi.00094.2004CrossRefPubMed Hines IN, Wheeler MD: Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2004, 287: G310-G314. 10.1152/ajpgi.00094.2004CrossRefPubMed
4.
go back to reference Saito H, Ishii H: Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res 2004, 30: 193-198. 10.1016/j.hepres.2004.08.016CrossRefPubMed Saito H, Ishii H: Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res 2004, 30: 193-198. 10.1016/j.hepres.2004.08.016CrossRefPubMed
5.
go back to reference Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34: 9-19. 10.1016/j.alcohol.2004.07.008CrossRefPubMed Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34: 9-19. 10.1016/j.alcohol.2004.07.008CrossRefPubMed
6.
go back to reference Nanji AA: Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34: 21-25. 10.1016/j.alcohol.2004.08.005CrossRefPubMed Nanji AA: Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34: 21-25. 10.1016/j.alcohol.2004.08.005CrossRefPubMed
7.
go back to reference Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA: Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27: 1317-1323. 10.1002/hep.510270518CrossRefPubMed Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA: Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27: 1317-1323. 10.1002/hep.510270518CrossRefPubMed
8.
go back to reference Sies H: Strategies of antioxidant defense. Eur J Biochem 1993, 215: 213-219. 10.1111/j.1432-1033.1993.tb18025.xCrossRefPubMed Sies H: Strategies of antioxidant defense. Eur J Biochem 1993, 215: 213-219. 10.1111/j.1432-1033.1993.tb18025.xCrossRefPubMed
9.
go back to reference Thiele GM, Freeman TL, Klassen LW: Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004, 24: 273-287. 10.1055/s-2004-832940CrossRefPubMed Thiele GM, Freeman TL, Klassen LW: Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004, 24: 273-287. 10.1055/s-2004-832940CrossRefPubMed
10.
go back to reference Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Torres E, Orfao A: Alcoholic liver cirrhosis is associated with a decreased expression of the CD28 costimulatory molecule, a lower ability of T cells to bind exogenous IL-2, and increased soluble CD8 levels. Cytometry 2000, 42: 290-295. 10.1002/1097-0320(20001015)42:5<290::AID-CYTO6>3.0.CO;2-5CrossRefPubMed Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Torres E, Orfao A: Alcoholic liver cirrhosis is associated with a decreased expression of the CD28 costimulatory molecule, a lower ability of T cells to bind exogenous IL-2, and increased soluble CD8 levels. Cytometry 2000, 42: 290-295. 10.1002/1097-0320(20001015)42:5<290::AID-CYTO6>3.0.CO;2-5CrossRefPubMed
11.
go back to reference Pruett SB, Schwab C, Zheng Q, Fan R: Suppression of innate immunity by acute ethanol administration: a global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J Immunol 173: 2715-2724. 8-15-2004 Pruett SB, Schwab C, Zheng Q, Fan R: Suppression of innate immunity by acute ethanol administration: a global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J Immunol 173: 2715-2724. 8-15-2004
12.
go back to reference Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, Adams DH: Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998, 186: 82-89. 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-DCrossRefPubMed Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, Adams DH: Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998, 186: 82-89. 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-DCrossRefPubMed
13.
go back to reference Bautista AP: Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 2000, 15: 349-356. 10.1046/j.1440-1746.2000.02174.xCrossRefPubMed Bautista AP: Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 2000, 15: 349-356. 10.1046/j.1440-1746.2000.02174.xCrossRefPubMed
14.
go back to reference Maltby J, Wright S, Bird G, Sheron N: Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996, 24: 1156-1160.PubMed Maltby J, Wright S, Bird G, Sheron N: Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996, 24: 1156-1160.PubMed
15.
go back to reference Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E: Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001, 99: 201-210. 10.1006/jsre.2001.6217CrossRefPubMed Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E: Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001, 99: 201-210. 10.1006/jsre.2001.6217CrossRefPubMed
16.
go back to reference Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K: The role of liver biopsy in chronic hepatitis C. Hepatology 2001, 33: 196-200. 10.1053/jhep.2001.20534CrossRefPubMed Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K: The role of liver biopsy in chronic hepatitis C. Hepatology 2001, 33: 196-200. 10.1053/jhep.2001.20534CrossRefPubMed
17.
go back to reference Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332: 130-144. 10.1016/j.virol.2004.11.009CrossRefPubMed Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332: 130-144. 10.1016/j.virol.2004.11.009CrossRefPubMed
18.
go back to reference Smith MW, Walters K-A, Korth MJ, Fitzgibbon M, Proll SC, Thompson JC, Yeh MM, Shuhart MC, Furlong JC, Cox PP, Thomas DL, Phillips JD, Kushner JP, Fausto N, Carithers RL, Katze MG: Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterol 2006, 130: 179-187. 10.1053/j.gastro.2005.08.015CrossRef Smith MW, Walters K-A, Korth MJ, Fitzgibbon M, Proll SC, Thompson JC, Yeh MM, Shuhart MC, Furlong JC, Cox PP, Thomas DL, Phillips JD, Kushner JP, Fausto N, Carithers RL, Katze MG: Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterol 2006, 130: 179-187. 10.1053/j.gastro.2005.08.015CrossRef
19.
go back to reference Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, ZhuLin-Fu Gao TJ, Knetman NM, Tyrrell DL, Katze MG: Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response. PLOS Pathogens 2: 591-601. 6-23-2006 Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, ZhuLin-Fu Gao TJ, Knetman NM, Tyrrell DL, Katze MG: Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response. PLOS Pathogens 2: 591-601. 6-23-2006
20.
go back to reference Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, Chayama K: Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 2005, 50: 1361-1371. 10.1007/s10620-005-2788-1CrossRefPubMed Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, Chayama K: Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 2005, 50: 1361-1371. 10.1007/s10620-005-2788-1CrossRefPubMed
21.
go back to reference Baas T, Taubenberger J, Chong PY, Chui P, Katze MG: SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res 2006, 26: 309-317. 10.1089/jir.2006.26.309PubMedCentralCrossRefPubMed Baas T, Taubenberger J, Chong PY, Chui P, Katze MG: SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res 2006, 26: 309-317. 10.1089/jir.2006.26.309PubMedCentralCrossRefPubMed
22.
go back to reference Korth MJ, Kash JC, Baskin CR, Katze MG: Insights into influenza virus-host interactions through global gene expression profiling: cell culture systems to animal models. 2006, 341-360. Korth MJ, Kash JC, Baskin CR, Katze MG: Insights into influenza virus-host interactions through global gene expression profiling: cell culture systems to animal models. 2006, 341-360.
23.
go back to reference Kash JC, Mühlberger E, Carter V, Grosch O, Perwitasari O, Proll SC, Thomas MJ, Weber F, Klenk H.-D, Katze MG: Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type 1 interferon response is associated with enhanced virulence. J Virol 2006, 80: 3009-3020. 10.1128/JVI.80.6.3009-3020.2006PubMedCentralCrossRefPubMed Kash JC, Mühlberger E, Carter V, Grosch O, Perwitasari O, Proll SC, Thomas MJ, Weber F, Klenk H.-D, Katze MG: Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type 1 interferon response is associated with enhanced virulence. J Virol 2006, 80: 3009-3020. 10.1128/JVI.80.6.3009-3020.2006PubMedCentralCrossRefPubMed
24.
go back to reference Korth MJ, Kash JC, Furlong JC, Katze MG: Virus infection and the interferon response: a global view through functional genomics. Methods Mol Med 2005, 116: 37-55.PubMed Korth MJ, Kash JC, Furlong JC, Katze MG: Virus infection and the interferon response: a global view through functional genomics. Methods Mol Med 2005, 116: 37-55.PubMed
25.
go back to reference Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K: A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995, 15: 300-306.CrossRefPubMed Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K: A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995, 15: 300-306.CrossRefPubMed
26.
go back to reference Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S: Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998, 28: 3448-3455. 10.1002/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5CrossRefPubMed Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S: Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998, 28: 3448-3455. 10.1002/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5CrossRefPubMed
27.
go back to reference Laso FJ, Madruga JI, Lopez A, Ciudad J, varez-Mon M, San Miguel J, Orfao A: Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol Clin Exp Res 1996, 20: 1564-1568. 10.1111/j.1530-0277.1996.tb01700.xCrossRefPubMed Laso FJ, Madruga JI, Lopez A, Ciudad J, varez-Mon M, San Miguel J, Orfao A: Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol Clin Exp Res 1996, 20: 1564-1568. 10.1111/j.1530-0277.1996.tb01700.xCrossRefPubMed
28.
go back to reference Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, Roselle GA, Nemchausky BA, Tamburro CH, Schiff ER: Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology 1993, 105: 254-266.PubMed Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, Roselle GA, Nemchausky BA, Tamburro CH, Schiff ER: Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology 1993, 105: 254-266.PubMed
29.
go back to reference Chiang JY: Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004, 40: 539-551. 10.1016/j.jhep.2003.11.006CrossRefPubMed Chiang JY: Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004, 40: 539-551. 10.1016/j.jhep.2003.11.006CrossRefPubMed
30.
go back to reference Koop DR, Tierney DJ: Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 1990, 12: 429-435. 10.1002/bies.950120906CrossRefPubMed Koop DR, Tierney DJ: Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 1990, 12: 429-435. 10.1002/bies.950120906CrossRefPubMed
31.
go back to reference Takahashi T, Lasker JM, Rosman AS, Lieber CS: Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993, 17: 236-245. 10.1016/0270-9139(93)90083-YPubMed Takahashi T, Lasker JM, Rosman AS, Lieber CS: Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993, 17: 236-245. 10.1016/0270-9139(93)90083-YPubMed
32.
go back to reference Bigger CB, Brasky KM, Lanford RE: DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001, 75: 7059-7066. 10.1128/JVI.75.15.7059-7066.2001PubMedCentralCrossRefPubMed Bigger CB, Brasky KM, Lanford RE: DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001, 75: 7059-7066. 10.1128/JVI.75.15.7059-7066.2001PubMedCentralCrossRefPubMed
33.
go back to reference Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992, 149: 3339-3344.PubMed Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992, 149: 3339-3344.PubMed
34.
go back to reference Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999, 30: 595-601. 10.1002/hep.510300312CrossRefPubMed Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999, 30: 595-601. 10.1002/hep.510300312CrossRefPubMed
35.
go back to reference Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG: Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003, 35: 1458-1467.CrossRef Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG: Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003, 35: 1458-1467.CrossRef
36.
go back to reference Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T: Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J Hepatol 2004, 41: 652-658. 10.1016/j.jhep.2004.06.021CrossRefPubMed Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T: Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J Hepatol 2004, 41: 652-658. 10.1016/j.jhep.2004.06.021CrossRefPubMed
37.
go back to reference Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B: Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 2004, 104: 478-486. 10.1182/blood-2003-12-4395CrossRefPubMed Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B: Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 2004, 104: 478-486. 10.1182/blood-2003-12-4395CrossRefPubMed
38.
go back to reference Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP, Marche PN, Jouvin-Marche E: Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003, 38: 829-841. 10.1053/jhep.2003.50410CrossRefPubMed Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP, Marche PN, Jouvin-Marche E: Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003, 38: 829-841. 10.1053/jhep.2003.50410CrossRefPubMed
39.
go back to reference Kusano F, Tanaka Y, Marumo F, Sato C: Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000, 80: 415-422.CrossRefPubMed Kusano F, Tanaka Y, Marumo F, Sato C: Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000, 80: 415-422.CrossRefPubMed
40.
go back to reference McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu D, Slaitini L, Church WB, Napoli J: Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000, 174: 172-191. 10.1034/j.1600-0528.2002.017420.xCrossRefPubMed McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu D, Slaitini L, Church WB, Napoli J: Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000, 174: 172-191. 10.1034/j.1600-0528.2002.017420.xCrossRefPubMed
41.
go back to reference Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996, 24: 759-765. 10.1002/hep.510240402CrossRefPubMed Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996, 24: 759-765. 10.1002/hep.510240402CrossRefPubMed
42.
go back to reference Cook RT: Alcohol abuse, alcoholism, and damage to the immune system – a review. Alcohol Clin Exp Res 1998, 22: 1927-1942.PubMed Cook RT: Alcohol abuse, alcoholism, and damage to the immune system – a review. Alcohol Clin Exp Res 1998, 22: 1927-1942.PubMed
43.
go back to reference Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK: Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res 2001, 25: 444-449. 10.1111/j.1530-0277.2001.tb02233.xPubMed Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK: Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res 2001, 25: 444-449. 10.1111/j.1530-0277.2001.tb02233.xPubMed
44.
go back to reference Pritchard MT, Nagy LE: Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005, 29: 146S-150S. 10.1097/01.alc.0000189286.81943.51CrossRefPubMed Pritchard MT, Nagy LE: Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005, 29: 146S-150S. 10.1097/01.alc.0000189286.81943.51CrossRefPubMed
45.
go back to reference Takeyama Y, Kamimura S, Kuroiwa A, Sohda T, Irie M, Shijo H, Okumura M: Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo. Alcohol Clin Exp Res 1996, 20: 335A-339A.CrossRefPubMed Takeyama Y, Kamimura S, Kuroiwa A, Sohda T, Irie M, Shijo H, Okumura M: Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo. Alcohol Clin Exp Res 1996, 20: 335A-339A.CrossRefPubMed
46.
go back to reference Neuman MG, Brenner DA, Rehermann B, Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, Katz GG, Cameron RG, Shear NH, Gao B, Takamatsu M, Yamauchi M, Ohata M, Saito S, Maeyama S, Uchikoshi T, Toda G, Kumagi T, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M: Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 2001, 25: 251S-253S. 10.1111/j.1530-0277.2001.tb02404.xCrossRefPubMed Neuman MG, Brenner DA, Rehermann B, Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, Katz GG, Cameron RG, Shear NH, Gao B, Takamatsu M, Yamauchi M, Ohata M, Saito S, Maeyama S, Uchikoshi T, Toda G, Kumagi T, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M: Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 2001, 25: 251S-253S. 10.1111/j.1530-0277.2001.tb02404.xCrossRefPubMed
47.
go back to reference Thurman RG: II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998, 275: G605-G611.PubMed Thurman RG: II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998, 275: G605-G611.PubMed
48.
go back to reference Bataller R, Sancho-Bru P, Gines P, Brenner DA: Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal 2005, 7: 1346-1355. 10.1089/ars.2005.7.1346CrossRefPubMed Bataller R, Sancho-Bru P, Gines P, Brenner DA: Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal 2005, 7: 1346-1355. 10.1089/ars.2005.7.1346CrossRefPubMed
49.
go back to reference Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J Biol Chem 2001, 276: 30118-30126. 10.1074/jbc.M102516200CrossRefPubMed Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J Biol Chem 2001, 276: 30118-30126. 10.1074/jbc.M102516200CrossRefPubMed
50.
go back to reference Koivisto T, Mishin VM, Mak KM, Cohen PA, Lieber CS: Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol Clin Exp Res 1996, 20: 207-212. 10.1111/j.1530-0277.1996.tb01631.xCrossRefPubMed Koivisto T, Mishin VM, Mak KM, Cohen PA, Lieber CS: Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol Clin Exp Res 1996, 20: 207-212. 10.1111/j.1530-0277.1996.tb01631.xCrossRefPubMed
52.
go back to reference Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG: Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 2001, 75: 4321-4331. 10.1128/JVI.75.9.4321-4331.2001PubMedCentralCrossRefPubMed Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG: Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 2001, 75: 4321-4331. 10.1128/JVI.75.9.4321-4331.2001PubMedCentralCrossRefPubMed
53.
go back to reference Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG: Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003, 75: 859-864. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG: Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003, 75: 859-864.
54.
go back to reference Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, Lazaro CA, Fausto N, Bumgarner RE, Katze MG: Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003, 77: 6367-6375. 10.1128/JVI.77.11.6367-6375.2003PubMedCentralCrossRefPubMed Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, Lazaro CA, Fausto N, Bumgarner RE, Katze MG: Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003, 77: 6367-6375. 10.1128/JVI.77.11.6367-6375.2003PubMedCentralCrossRefPubMed
55.
go back to reference Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FCP, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nature Genet 2001, 29: 365-371. 10.1038/ng1201-365CrossRefPubMed Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FCP, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nature Genet 2001, 29: 365-371. 10.1038/ng1201-365CrossRefPubMed
Metadata
Title
Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis
Authors
Sharon L Lederer
Kathie-Anne Walters
Sean Proll
Bryan Paeper
Shahar Robinzon
Loreto Boix
Nelson Fausto
Jordi Bruix
Michael G Katze
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2006
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-3-98

Other articles of this Issue 1/2006

Virology Journal 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine